| NCT06677801 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Systemic Lupus Erythematosus (SLE) | 2024-10-11 | PHASE4 |
| NCT05247203 | RemeGen Co., Ltd. | Systemic Lupus Erythematosus | 2022-05-11 | PHASE1 |
| NCT05929248 | Guanmin Gao | Systemic Lupus Erythematosus | 2023-07-01 | PHASE2 |
| NCT06546540 | Peking University Third Hospital | Systemic Sclerosis | 2024-06-08 | PHASE4 |
| NCT06979271 | Zhejiang Provincial People´s Hospital | Telitacicept|Treatment Compliance|Rheumatoid Arthritis | 2025-06-01 | |
| NCT05306574 | Vor Biopharma | Systemic Lupus Erythematosus | 2022-06-20 | PHASE3 |
| NCT07522099 | ADARx Pharmaceuticals, Inc. | Immunoglobulin A Nephropathy (IgAN)|Complement 3 Glomerulopathy (C3G)|IC-MPGN | 2026-07-23 | PHASE2 |
| NCT05588830 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Lupus Nephritis|Belimumab|Telitacicept | 2022-10-20 | |
| NCT05078710 | Peking Union Medical College Hospital | Anti Phospholipid Syndrome | 2021-07-01 | PHASE2 |
| NCT07355257 | Zhongming Qiu | Inflammatory Myopathy | 2026-02-02 | PHASE2|PHASE3 |
| NCT06125405 | The Children´s Hospital of Zhejiang University School of Medicine | Nephrotic Syndrome in Children|Telitacicept | 2023-11-28 | PHASE3 |
| NCT05799287 | RemeGen Co., Ltd. | Primary IgA Nephropathy | 2023-04-28 | PHASE3 |
| NCT05998759 | Beijing Hospital|The First Affiliated Hospital of Anhui Medical University|The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)|Peking University People´s Hospital|Peking University Third Hospital|First Affiliated Hospital, Sun Yat-Sen University|Guangdong Provincial People´s Hospital|The First Affiliated Hospital of Zhengzhou University|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology|Second Xiangya Hospital of Central South University|Xiangya Hospital of Central South University|The Affiliated Hospital of Inner Mongolia Medical University|First Hospital of China Medical University|Shandong Provincial Hospital|Changhai Hospital|RenJi Hospital|Shanxi Bethune Hospital|West China Hospital|Institute of Hematology & Blood Diseases Hospital, China|Tianjin First Central Hospital|Tianjin Medical University General Hospital|People´s Hospital of Xinjiang Uygur Autonomous Region|The First People´s Hospital of Yunnan | Connective Tissue Diseases|Thrombocytopenia | 2023-12-02 | PHASE2 |
| NCT07098897 | The Affiliated Hospital of Xuzhou Medical University | IgA Nephropathy (IgAN) | 2024-08-01 | PHASE3 |
| NCT07298928 | The Children´s Hospital of Zhejiang University School of Medicine | Effectiveness | 2026-03-10 | NA |
| NCT06375005 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Diffuse Cutaneous Systemic Sclerosis | 2025-01-06 | PHASE2 |
| NCT05965284 | Chinese SLE Treatment And Research Group | ANCA-associated Vasculitis|Maintenance Therapy | 2023-03-09 | PHASE4 |
| NCT06394063 | RenJi Hospital | Systemic Lupus Erythematosus | 2024-06-28 | NA |
| NCT05737160 | RemeGen Co., Ltd. | Myasthenia Gravis, Generalized | 2023-03-28 | PHASE3 |
| NCT05339217 | Liu Tian | Systemic Lupus Erythematosus | 2023-02-07 | PHASE3 |
| NCT07111338 | Peking University First Hospital | Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits | 2025-07-12 | PHASE2 |
| NCT07495033 | RemeGen Co., Ltd. | CTD-ILD | 2026-04-20 | PHASE3 |
| NCT07340463 | Nanjing University School of Medicine | Systemic Lupus Erythematosus (SLE)|Lupus Nephritis (LN) | 2025-12-08 | PHASE2 |
| NCT06827587 | First Affiliated Hospital of Wenzhou Medical University|Zhejiang Provincial People´s Hospital|Sir Run Run Shaw Hospital|Second Affiliated Hospital, School of Medicine, Zhejiang University|Ningbo Medical Center Lihuili Hospital | Myasthenia Gravis|Autoimmune Diseases|Neuromuscular Diseases | 2025-02 | NA |
| NCT06456580 | Vor Biopharma | Generalized Myasthenia Gravis | 2024-07-17 | PHASE3 |
| NCT06456567 | Vor Biopharma | Systemic Lupus Erythematosus | 2024-09 | PHASE3 |
| NCT04905212 | RemeGen Co., Ltd. | IgA Nephropathy | 2021-11-04 | PHASE2 |
| NCT06723548 | First Affiliated Hospital of Wenzhou Medical University | Myasthenia Gravis|Autoimmune Diseases | 2024-12 | PHASE4 |
| NCT05596708 | Second Affiliated Hospital, School of Medicine, Zhejiang University | IgA Nephropathy | 2023-03-01 | PHASE2|PHASE3 |
| NCT06549959 | RemeGen Co., Ltd. | Healthy | 2024-08-05 | PHASE1 |
| NCT07077486 | Tongji Hospital|Wuhan Central Hospital|Wuhan Hospital of Traditional Chinese Medicine|Rongchang Biopharmaceutical|Johns Hopkins Bloomberg School of Public Health | Lupus or SLE|Interstitial Lung Disease|Systemic Lupus Erythematosus | 2025-08-25 | PHASE4 |
| NCT06614985 | Renmin Hospital of Wuhan University | Primary Membranous Nephropathy | 2024-10-20 | PHASE2 |
| NCT06654596 | Ruijin Hospital|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|RenJi Hospital|Sichuan Provincial People´s Hospital|Renmin Hospital of Wuhan University|Shanghai 6th People´s Hospital|Shanghai Longhua Hospital|Huashan Hospital|Shanghai Changzheng Hospital|Wannan Medical College Yijishan Hospital|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine | IgA Nephropathy (IgAN)|Kidney Diseases|Telitacicept|Glucocorticoid | 2024-12-06 | NA |
| NCT07008196 | Chinese SLE Treatment And Research Group | Rheumatoid Arthritis (RA) | 2025-06-10 | PHASE4 |
| NCT05680480 | RemeGen Co., Ltd. | Lupus Nephritis | 2023-04-17 | PHASE2 |
| NCT05899907 | Peking Union Medical College Hospital|RemeGen Co., Ltd. | Lupus Erythematosus, Systemic | 2022-09-01 | PHASE4 |
| NCT07249632 | RemeGen Co., Ltd.|Huashan Hospital|Beijing Hospital | Myasthenia Gravis, Ocular | 2026-01-13 | PHASE3 |
| NCT07052981 | Guixia Ding | IgA Nephropathy (IgAN)|IgAVN | 2025-08-01 | PHASE3 |
| NCT06656962 | Renmin Hospital of Wuhan University | Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN) | 2024-10-10 | PHASE1|PHASE2 |
| NCT05962840 | Chinese SLE Treatment And Research Group|Peking Union Medical College Hospital | ANCA Associated Vasculitis | 2023-06-29 | PHASE4 |
| NCT05687526 | RemeGen Co., Ltd. | Systemic Lupus Erythematosus | 2023-05-25 | PHASE1 |
| NCT05673993 | RemeGen Co., Ltd. | Primary Sjogren´s Syndrome | 2023-04-06 | PHASE3 |
| NCT04235933 | RemeGen Co., Ltd. | Healthy | 2019-09-17 | PHASE1 |
| NCT04625153 | RemeGen Co., Ltd. | Multiple Sclerosis, Relapsing-Remitting | 2021-05-13 | PHASE2 |
| NCT04302103 | RemeGen Co., Ltd. | Systemic Myasthenia Gravis | 2020-07-07 | PHASE2 |
| NCT04291781 | RemeGen Co., Ltd. | Primary IgA Nephropathy | 2020-04-13 | PHASE2 |
| NCT04078386 | RemeGen Co., Ltd. | Primary Sj?gren´s Syndrome | 2019-11-21 | PHASE2 |
| NCT02885610 | RemeGen Co., Ltd. | Systemic Lupus Erythematosus | 2015-12 | PHASE2 |
| NCT03016013 | RemeGen Co., Ltd. | Moderate and Severe RheumatoId Arthritis | 2017-03-29 | PHASE3 |
| NCT03330418 | RemeGen Co., Ltd. | Neuromyelitis Optica Spectrum Disorders | 2018-01-29 | PHASE3 |
| NCT02882087 | RemeGen Co., Ltd. | Moderate and Severe Rheumatoid Arthritis | 2015-10 | PHASE2 |
| NCT04082416 | RemeGen Co., Ltd. | Systemic Lupus Erythematosus | 2019-10-16 | PHASE3 |